Clinical trials: Attention-Deficit and Hyperactivity Disorder
Attention Deficit Hyperactivity Disorder
Safety Study in Outpatient Japanese Children With ADHD
Evaluate the safety and efficacy of atomoxetine in Japanese pediatric patients with ADHD.
- Trial name
- NCT00485628
- Testing
- Atomoxetine Hydrochloride
- Where
- Japan
- Volunteers
- 37 people
- Sponsor
- Eli Lilly and Company
Attention Deficit Hyperactivity Disorder
Preference and Goal Directed Attention Deficit Hyperactivity Disorder Care- Pilot Study
This pilot intervention study will test the feasibility and acceptability and explore the outcomes of an urban, primary care-based intervention to measure families' preferences and goals for Attention-Deficit/Hyperactivity…
- Trial name
- NCT01487967
- Testing
- Preference and Goal Instrument
- Where
- United States
- Volunteers
- 120 people
- Sponsor
- Children's Hospital of Philadelphia
Attention Deficit Disorder With Hyperactivity
Support for PARents of Children Living With ADHD - a Research Trial
Attention-Deficit/Hyperactivity Disorder (ADHD) is a chronic and pervasive disorder characterised by problems in attention, impulse control and activity regulation that substantially burdens patients, families, and society.
- Trial name
- SPARCLAR (NCT03832270)
- Testing
- Parents InC, Incredible Years
- Where
- United Kingdom
- Volunteers
- 60 people
- Sponsor
- University of Glasgow
Attention Deficit Disorder With or Without Hyperactivity (ADHD), Children
Evaluation of the LUSHA Digital Application for Children With ADHD - Feasibility Study
Attention Deficit Disorder with or without Hyperactivity (ADHD) is a neurodevelopmental disorder characterized by a triad of symptoms combining inattention, hyperactivity, and/or impulsivity.
- Trial name
- LUSHA (NCT07204873)
- Testing
- LUSHA digital app
- Where
- 2 sites in France
- Volunteers
- 80 people
- Sponsor
- University Hospital, Grenoble
ADHD, Autism Spectrum Disorder
AWARE: Management of ADHD in Autism Spectrum Disorder
This study is a pragmatic clinical trial examining the comparative effectiveness of two stimulant medications (methylphenidate and amphetamine) in the treatment of ADHD in children and adolescents with autism.
- Trial name
- NCT05916339
- Testing
- Randomization to either Amphetamine (AMP) class of stimulant medication or Methylphenidate (MPH) class of stimulant medication, Randomization to either Alpha 2 agonist class of medication or alternate class of stimulant.
- Where
- 13 sites in United States, Canada
- Volunteers
- 500 people
- Sponsor
- Daniel Coury
ADHD
CLONICEL (Clonidine Sustained Release) as Add-on to Stimulant Medication in 6 to 17 Yr-olds With ADHD
The purpose of this study is to determine if CLONICEL (clonidine HCl sustained release) is a safe and effective add-on to psychostimulant therapy in children and adolescents with attention deficit hyperactivity disorder (ADHD).
- Trial name
- NCT00641329
- Testing
- CLONICEL (clonidine HCl sustained release)
- Where
- 23 sites in United States
- Volunteers
- 198 people
- Sponsor
- Addrenex Pharmaceuticals, Inc.
Sensory Integration Dysfunction
The Relationship Between Brain Volume and Sensory Integration in Autistic and Attention Deficit Hyperactivity Disorder.
The relationship between brain volume and sensory integration in children and adolescence with attention deficit hyperactivity disorder and autistic spectrum disorder; comparative study
- Trial name
- NCT05260502
- Volunteers
- 105 people, healthy volunteers welcome
- Sponsor
- Assiut University
ADHD - Attention Deficit Disorder With Hyperactivity
Retail-Grade Weighted Blanket Effectiveness on ADHD-related Sleep Disturbances (BEAD)
The goal of this clinical trial is to investigate if a commercially available (retail-grade) weighted blanket can improve sleep in children with Attention Deficit Hyperactivity Disorder (ADHD) and sleep disturbances.
- Trial name
- Sweet BEAD (NCT07588659)
- Testing
- Sleep Intervention with weighted device
- Where
- Denmark
- Volunteers
- 100 people
- Sponsor
- University Hospital Bispebjerg and Frederiksberg
Behavioural Disorder, Disruptive Behavior Disorder
Personalizing Psychosocial Intervention for Children With Disruptive Behaviour
This study will develop and test whether personalized profiles of children with Disruptive Behaviour Disorder (DBD) and their parents based on important psychological, emotional, and neuropsychological indicators predict their…
- Conditions
- Behavioural Disorder, Disruptive Behavior Disorder, Attention Deficit Hyperactivity Disorder, Conduct Disorder
- Trial name
- MATCH-PIP (NCT07495683)
- Testing
- Behavioral Parent Training
- Volunteers
- 600 people
- Sponsor
- Centre for Addiction and Mental Health
Attention Deficit/Hyperactivity Disorder
Safety and Tolerability Study of Adhansia XR® Extended-Release Capsules in Children
The purpose of this study is to assess the long-term safety of Adhansia XR in children and to characterize the pharmacokinetics (PK) in 4 to 5 year-olds.
- Trial name
- NCT04987762
- Testing
- Adhansia XR
- Where
- 15 sites in United States
- Volunteers
- 103 people
- Sponsor
- Purdue Pharma LP
ADHD, Autism
Acceptability, Feasibility, and Development of an AI Driven, Multi-sensor, Non-invasive Digital Mental Health Platform in Children With ADHD and Emotional Symptoms
This is an observational study collecting data using a wearable to measure the biometric features in youth with Attention deficit hyperactivity disorder(ADHD) and Autism.
- Trial name
- NCT06311370
- Testing
- Observation
- Where
- United States
- Volunteers
- 10 people
- Sponsor
- MaxisHealth
Attention-Deficit/Hyperactivity Disorder
A Safety and Efficacy Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)
The purpose of this study is to test if the investigational medication ABT-089 is a safe and effective treatment for children with Attention-Deficit/Hyperactivity Disorder or ADHD.
- Trial name
- NCT00528697
- Testing
- ABT-089, atomoxetine
- Where
- 20 sites in United States
- Volunteers
- 278 people
- Sponsor
- AbbVie (prior sponsor, Abbott)
ADHD, Attention Deficit Hyperactivity Disorder
A Study of Combination Therapy in Children With ADHD
Lack of appetite and weight loss are a common side effect of ADHD therapy with amphetamines such as methylphenidate. Lack of sufficient food intake has been shown to have negative effects on weight and height as well as learning…
- Conditions
- ADHD, Attention Deficit Hyperactivity Disorder, Attention Deficit Disorder With Hyperactivity, Mental Disorders Diagnosed in Childhood
- Trial name
- NCT01940978
- Testing
- Methylphenidate ER, Cyproheptadine
- Where
- United States
- Volunteers
- 99 people
- Sponsor
- Douglas Sears
Attention Deficit/Hyperactivity Disorder
Comparative Effectiveness Research for Two Medical Home Models for Attention Deficit Hyperactivity Disorder
The purpose of this study is to compare the effectiveness of two care models on ADHD outcomes: one, a model of basic care management and structured communication with specialists, consistent with conventional descriptions of a…
- Trial name
- NCT01275378
- Testing
- Collaborative Care Plus, Traditional Collaborative Care
- Where
- United States
- Volunteers
- 156 people, healthy volunteers welcome
- Sponsor
- Boston Medical Center
Child Behavior Problem, Disruptive Behavior
Pilot Study of Parent Training With Role-plays in Virtual Reality for Parents of Children With Behavior Problems
The main aim of this pilot trial is to evaluate preliminary effects and feasibility of a new parent training program for parents of children aged 8-16 years with disruptive behavior (e.g., angry, aggressive or defiant behavior).
- Conditions
- Child Behavior Problem, Disruptive Behavior, Oppositional Defiant Disorder, Conduct Problems
- Trial name
- NCT06559813
- Testing
- Step-by-step: A cognitive behavioral parent program with role-plays in virtual reality
- Where
- Sweden
- Volunteers
- 8 people
- Sponsor
- Karolinska Institutet
Attention Deficit Hyperactivity Disorder
Deep Transcranial Magnetic Stimulation (DTMS) as a Treatment for Attention Deficit Hyperactivity Disorder (ADHD) in Adults
The aim of the study is to assess the effect of left or right high-frequency DTMS on ADHD symptoms, cognitive performance and decision-making ability of ADHD adults, and to compare this to the effect of sham DTMS on ADHD adults
- Trial name
- NCT01196910
- Testing
- treatment by HLPFC coil
- Where
- Israel
- Volunteers
- 45 people
- Sponsor
- Brainsway
Academic Acheivement, Attention
The Effects of Breathing Exercises on Exam Anxiety, Attention Deficit, and Academic Achievement in Students Preparing for University Entrance Exams
This study investigates the effects of breathing exercises on exam anxiety, attention, and academic achievement in students preparing for university entrance exams.
- Conditions
- Academic Acheivement, Attention, Exam Anxiety, Breathing Exercises
- Trial name
- NCT07158060
- Testing
- Breathing Exercises
- Volunteers
- 60 people
- Sponsor
- Istanbul University - Cerrahpasa
Insomnia, Disruptive Behavior Disorder
Behavioral Sleep Intervention in Children With Disruptive Behaviors
Despite the high prevalence of sleep difficulties in children with disruptive behavior disorders, little is known about the role of sleep in treating disruptive behavior.
- Conditions
- Insomnia, Disruptive Behavior Disorder, Oppositional Defiant Disorder
- Trial name
- NCT02783560
- Testing
- The Sleep Train Program, The Family Mealtimes Program
- Volunteers
- 24 people
- Sponsor
- Indiana University
Attention Deficit Hyperactivity Disorder
Sequencing Treatments for Mothers With ADHD and Their At - Risk Children
We hypothesize that successfully treating maternal Attention Deficit Hyperactivity Disorder (ADHD) will have a beneficial effect that extends to the child.
- Trial name
- TMF (NCT01816074)
- Testing
- Vyvanse (lisdexamphetamine), Behavior Parent Training
- Where
- United States
- Volunteers
- 53 people
- Sponsor
- Seattle Children's Hospital
Attention Deficit Hyperactivity Disorder
A Follow-up, Family Study on Attention-deficit Hyperactivity Disorder
Background: Attention deficit hyperactivity disorder (ADHD), characterized by inattention, hyperactivity and impulsivity, is an early onset, common (5-10% worldwide; 7.5% in Taiwan), clinically heterogeneous, impairing disorder.
- Trial name
- NCT00417781
- Where
- Taiwan
- Volunteers
- 1,800 people
- Sponsor
- National Taiwan University Hospital
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.